US Patent Issued to NEUROBIOMAT on April 14 for "Hybrid heterogeneous hydrogel, manufacturing method and use as an in-situ non-degradable filler implant" (French Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,703, issued on April 14, was assigned to NEUROBIOMAT (Archamps, France).

"Hybrid heterogeneous hydrogel, manufacturing method and use as an in-situ non-degradable filler implant" was invented by Stephane Woerly (Saint Julien en Genevois, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "A filler implant includes a support of hybrid heterogeneous hydrogel which is formed by a copolymer including: a dendrimer monomer which is functionalised by an ethylene radical, an acryl amide compound which is selected from an N-substituted methacrylamide and N-substituted acrylamide, a cross-linking agent and a bioactive copolymerisable material. The support ...